These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32197584)
1. A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex. Axelsson S; Magnuson A; Lange A; Alshamari A; Hörnquist EH; Hultgren O BMC Immunol; 2020 Mar; 21(1):14. PubMed ID: 32197584 [TBL] [Abstract][Full Text] [Related]
2. BTLA Expression and Function Are Impaired on SLE B Cells. Wiedemann A; Lettau M; Weißenberg SY; Stefanski AL; Schrezenmeier EV; Rincon-Arevalo H; Reiter K; Alexander T; Hiepe F; Lino AC; Dörner T Front Immunol; 2021; 12():667991. PubMed ID: 33968071 [TBL] [Abstract][Full Text] [Related]
3. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. Lorenzetti R; Janowska I; Smulski CR; Frede N; Henneberger N; Walter L; Schleyer MT; Hüppe JM; Staniek J; Salzer U; Venhoff A; Troilo A; Voll RE; Venhoff N; Thiel J; Rizzi M J Autoimmun; 2019 Jul; 101():145-152. PubMed ID: 31054942 [TBL] [Abstract][Full Text] [Related]
5. BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3 Zhang JA; Lu YB; Wang WD; Liu GB; Chen C; Shen L; Luo HL; Xu H; Peng Y; Luo H; Huang GX; Wu DD; Zheng BY; Yi LL; Chen ZW; Xu JF Front Immunol; 2020; 11():518. PubMed ID: 32296431 [TBL] [Abstract][Full Text] [Related]
6. BTLA-expressing CD11c antigen presenting cells in patients with active tuberculosis exhibit low capacity to stimulate T cell proliferation. Wang WD; Gao YC; Lu YB; Zhang JA; Liu GB; Kong B; Xiang WY; Dai YC; Yu SY; Jia Y; Fu XX; Yi LL; Zheng BY; Chen ZW; Zhong J; Xu JF Cell Immunol; 2017 Jan; 311():28-35. PubMed ID: 27717503 [TBL] [Abstract][Full Text] [Related]
7. B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation. Liu Y; Nie W; Jin Y; Zhuo A; Zang Y; Xiu Q Iran J Immunol; 2016 Jun; 13(2):89-99. PubMed ID: 27350630 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells. Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715 [TBL] [Abstract][Full Text] [Related]
9. Increased expression levels of FcγRIIB on naïve and double-negative memory B cells in patients with systemic sclerosis. Yagi-Numata N; Matsushita T; Takehara K; Hamaguchi Y Clin Exp Rheumatol; 2019; 37 Suppl 119(4):23-31. PubMed ID: 30719970 [TBL] [Abstract][Full Text] [Related]
10. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. Hurchla MA; Sedy JR; Murphy KM J Immunol; 2007 May; 178(10):6073-82. PubMed ID: 17475832 [TBL] [Abstract][Full Text] [Related]
11. The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells. Werner K; Dolff S; Dai Y; Ma X; Brinkhoff A; Korth J; Gäckler A; Rohn H; Sun M; Cohen Tervaert JW; van Paassen P; Kribben A; Witzke O; Wilde B Front Immunol; 2019; 10():2843. PubMed ID: 31921121 [No Abstract] [Full Text] [Related]
12. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation. Zhang Z; Xu X; Lu J; Zhang S; Gu L; Fu J; Jin L; Li H; Zhao M; Zhang J; Wu H; Su L; Fu YX; Wang FS J Infect Dis; 2011 Jun; 203(11):1668-78. PubMed ID: 21592997 [TBL] [Abstract][Full Text] [Related]
13. Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Groth C; Drager R; Warnatz K; Wolff-Vorbeck G; Schmidt S; Eibel H; Schlesier M; Peter HH Clin Exp Immunol; 2002 Jul; 129(1):133-9. PubMed ID: 12100033 [TBL] [Abstract][Full Text] [Related]
14. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Sato S; Fujimoto M; Hasegawa M; Takehara K Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368 [TBL] [Abstract][Full Text] [Related]
15. BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine. Kannan S; Kurupati RK; Doyle SA; Freeman GJ; Schmader KE; Ertl HC Oncotarget; 2015 Aug; 6(23):19445-55. PubMed ID: 26277622 [TBL] [Abstract][Full Text] [Related]
16. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422 [TBL] [Abstract][Full Text] [Related]
17. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection. Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109 [TBL] [Abstract][Full Text] [Related]
18. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells. Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053 [TBL] [Abstract][Full Text] [Related]
19. High expression of BTLA and B7-H4 on the surface of myeloid dendritic cells has a negative regulatory effect on their anti-tuberculosis immunity activity in pleural tuberculosis patients. Cai X; Ge N; Rong R; Lu Y; Zhang J; Xu J Tuberculosis (Edinb); 2019 Dec; 119():101877. PubMed ID: 31677529 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model]. Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]